ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| 1 |
Tesla
TSLA
|
$91.5M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$43.5M |
| 3 |
TWOU
2U, Inc.
TWOU
|
$33.4M |
| 4 |
CRISPR Therapeutics
CRSP
|
$33M |
| 5 |
Nutanix
NTNX
|
$31.8M |
Top Sells
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
$101M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
$50M |
| 3 |
LendingTree
TREE
|
$49.3M |
| 4 |
Baidu
BIDU
|
$39.2M |
| 5 |
NVIDIA
NVDA
|
$35.7M |
Sector Composition
| 1 | Healthcare | 30.31% |
| 2 | Technology | 26.14% |
| 3 | Communication Services | 11.17% |
| 4 | Financials | 10.19% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Netflix
NFLX
$519B
| $43.2M | 1.09% |
117,628
-73,747
| -39% | -$27.1M |
|
|
27
LendingTree
TREE
$933M
| $41.6M | 1.05% |
99,017
-117,292
| -54% | -$49.3M |
|
|
28
Nutanix
NTNX
$18.2B
| $36.6M | 0.92% |
1,412,100
+1,224,081
| +651% | +$31.8M |
|
|
SYRS
29
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $35.1M | 0.88% |
3,791,756
+799,056
| +27% | +$7.4M |
|
30
Compugen
CGEN
$134M
| $32.6M | 0.82% |
8,496,641
+267,086
| +3% | +$1.03M |
|
31
Pluri
PLUR
$40.2M
| $32M | 0.81% |
5,156,645
+1,363,396
| +36% | +$8.46M |
|
32
Meta Platforms (Facebook)
META
$1.85T
| $31.4M | 0.79% |
+162,707
| New | +$31.4M |
|
33
Eventbrite
EB
$265M
| $26.7M | 0.67% |
1,647,777
+915,824
| +125% | +$14.8M |
|
34
Grayscale Bitcoin Trust
GBTC
$44.9B
| $25.8M | 0.65% |
1,704,557
-2,204,931
| -56% | -$33.4M |
|
35
Alibaba
BABA
$325B
| $25.8M | 0.65% |
152,159
+21,372
| +16% | +$3.62M |
|
36
Seres Therapeutics
MCRB
$161M
| $22.7M | 0.57% |
7,038,885
+1,751,172
| +33% | +$5.64M |
|
|
XONE
37
DELISTED
The ExOne Company
XONE
| $21.5M | 0.54% |
2,304,554
+133,363
| +6% | +$1.24M |
|
38
Amazon
AMZN
$2.4T
| $21.2M | 0.53% |
11,183
-3,856
| -26% | -$7.3M |
|
39
Iovance Biotherapeutics
IOVA
$792M
| $19.8M | 0.5% |
807,688
+116,194
| +17% | +$2.85M |
|
40
Apple
AAPL
$3.53T
| $17.7M | 0.45% |
89,502
-132,634
| -60% | -$26.3M |
|
41
PayPal
PYPL
$66.5B
| $17.4M | 0.44% |
152,299
-14,563
| -9% | -$1.67M |
|
|
CLLS
42
Cellectis
CLLS
$259M
| $17.2M | 0.43% |
1,103,186
+169,110
| +18% | +$2.64M |
|
43
Bristol-Myers Squibb
BMY
$96.7B
| $16M | 0.4% |
352,421
+158,104
| +81% | +$7.17M |
|
|
BLUE
44
DELISTED
bluebird bio
BLUE
| $13.8M | 0.35% |
108,341
-47,167
| -30% | -$6M |
|
45
Pinduoduo
PDD
$176B
| $13.8M | 0.35% |
667,560
+257,821
| +63% | +$5.32M |
|
|
CLDR
46
DELISTED
Cloudera, Inc.
CLDR
| $13.4M | 0.34% |
2,544,376
+1,031,617
| +68% | +$5.43M |
|
47
Inovio Pharmaceuticals
INO
$143M
| $11.6M | 0.29% |
3,955,017
+1,025,420
| +35% | +$3.01M |
|
48
Incyte
INCY
$17B
| $11.1M | 0.28% |
130,737
+63,432
| +94% | +$5.39M |
|
|
VIVS
49
VivoSim Labs, Inc. Common Stock
VIVS
$6.6M
| $11.1M | 0.28% |
21,132,709
+1,134,039
| +6% | +$593K |
|
|
RUBY
50
DELISTED
Rubius Therapeutics, Inc
RUBY
| $11M | 0.28% |
698,402
+168,787
| +32% | +$2.66M |
|